C. Brooks

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

P. Moayyedi, H. Barr, C. Edwards, 2018, The Lancet.

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol

P. Hoskin, C. Roberts, T. Maughan, 2020, BMC Cancer.

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus

Simon C. Potter, M. Pirinen, P. Donnelly, 2012, Nature Genetics.

Management of women who test positive for high-risk types of human papillomavirus: the HART study

U Menon, J Cuzick, G Terry, 2003, The Lancet.

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol

P. Hoskin, C. Roberts, T. Maughan, 2020, BMC Cancer.

A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring — supporting patients in their homes

Lionel Tarassenko, Andrew Weaver, Oliver Gibson, 2014, Supportive Care in Cancer.